Castle Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	604	581	620	1,085	1,337	587	-	-
Market Cap Growth	-	-6.38%	-42.81%	-18.88%	127.84%	-	-	-
Enterprise Value	377	353	375	763	927	513	20	17
PE Ratio	-10.11	-10.11	-9.24	-34.66	-130.01	196.20	-	-
PS Ratio	2.75	2.64	4.53	11.53	21.34	11.32	-	-
PB Ratio	1.54	1.48	1.55	2.63	3.22	6.90	-	-
P/FCF Ratio	-30.19	-30.19	-13.17	-48.30	261.29	96.55	-	-
P/OCF Ratio	-103.22	-103.22	-14.89	-57.14	135.53	83.65	-	-
EV/Sales Ratio	1.71	1.61	2.74	8.11	14.80	9.89	0.88	1.26
EV/EBITDA Ratio	-7.84	-7.84	-6.43	-20.85	-130.70	49.92	-5.32	-1.67
EV/EBIT Ratio	-6.15	-6.15	-5.44	-19.07	-122.55	51.73	-4.90	-1.62
EV/FCF Ratio	-18.35	-18.35	-7.96	-33.98	181.20	84.42	-1.59	-1.37
Debt / Equity Ratio	0.04	0.04	0.03	0.02	-	0.30	-0.43	-0.37
Debt / EBITDA Ratio	-0.34	-0.34	-0.23	-0.22	-	2.44	-6.51	-1.79
Debt / FCF Ratio	-0.80	-0.80	-0.28	-0.36	-	4.13	-1.95	-1.46
Quick Ratio	5.93	5.93	7.84	13.99	20.30	7.48	2.84	1.42
Current Ratio	6.20	6.20	8.09	14.22	20.58	7.63	2.69	1.28
Asset Turnover	0.51	0.51	0.30	0.21	0.26	0.73	1.41	-
Interest Coverage	-5214.00	-5214.00	-4052.18	-40011.00	-2.87	2.17	-1.80	-6.49
Return on Equity (ROE)	-14.90%	-14.90%	-16.50%	-7.50%	-5.00%	21.00%	19.00%	-
Return on Assets (ROA)	-13.20%	-13.20%	-14.90%	-7.10%	-4.20%	4.20%	-63.10%	-
Return on Capital (ROIC)	-16.72%	-16.72%	-22.10%	-9.55%	-1.57%	6.56%	11.96%	34.38%
Earnings Yield	-9.51%	-9.90%	-10.82%	-2.89%	-0.77%	0.51%	-	-
FCF Yield	-3.18%	-3.31%	-7.59%	-2.07%	0.38%	1.04%	-	-
Buyback Yield / Dilution	-2.87%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%	-0.55%	-
Total Shareholder Return	-2.87%	-2.87%	-3.65%	-32.80%	-118.63%	-354.25%	-0.55%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).